| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : 2007 : ASCPT 2007 | published Mon, Nov 10, 2008 - 15:27 EST |
| Name | Description | Page Modified |
| Model-Based Evaluations to Select and Confirm Doses in the Clinical Development of Exenatide | Cognigen's Primary Author: Luann Phillips, Amylin Pharmaceuticals Primary Author: Mark Fineman | Mon Jan 21 14:05:37 EST 2008 |
| Effect of Lifestyle Intervention on the Placebo Response in Anti-Obesity Trials: Considerations for Exposure-Response Modeling | Cognigen's Primary Author: Brenda Cirincione, Amylin Pharmaceuticals Primary Author: Amy Halseth | Mon Jan 21 14:05:39 EST 2008 |
| Population Pharmacokinetics of Paliperidone ER in Healthy Subjects and Patients with Schizophrenia | Primary Cognigen Author:P B. Cirincione; Primary John & Johnson Pharmaceutical Research Author: A. Vermeulen | Tue Oct 21 13:48:04 EDT 2008 |
| Cognigen Corporation - Posters and Presentations : 2007 : ASCPT 2007 | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |